Skyhawk’s latest biopharma collaboration is worth up to $1.8B



Skyhawk has also previously unveiled partnerships with the likes of Vertex Pharmaceuticals Inc., Bristol Myers Squibb, Takeda Pharmaceuticals, Genentech and Biogen Inc.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *